Download App

Log in to access Online Inquiry
Company Overview More
Cornerstone Pharmaceutical is a Chinese investment holding company. The company, through its subsidiaries, is mainly engaged in the R & D, production and sales of biopharmaceutical products. The company's main products are tumor immunotherapy and molecular targeted drugs. The company mainly does business in China.
CEO: Ningjun Jiang
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

02616 CSTONE PHARMA-B
5.0400.0000.00%
YOY
Do not show
Hide blank lines
(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30(FY)2019/12/31
Assets
Current assets
Inventory
-- 30.14M -- -- -- -- -- --
Accounts receivable
-- 50.42M -- -- -- -- -- --
Advance deposits and other receivables
12.11% 119.82M 23.98% 178.04M 102.12% 106.88M 205.63% 143.6M
Cash and equivalents
41.1% 2.45B 168.51% 3.02B 4.44% 1.73B 60.61% 1.13B
Fixed time deposit-current assets
-- -- -77.56% 358.87M -76.74% 389.37M 110.12% 1.6B
Secured deposit
-- -- 16.13% 720K 16.13% 720K -- 620K
Financial assets at fair value-current assets
-15.3% 10.29M -- -- 3.42% 12.15M -- --
Special items of current assets
-- -- -39.58% 10.13M -- -- -78.69% 16.76M
Total current assets
18.47% 2.66B 23.74% 3.57B -34% 2.24B 79.87% 2.89B
Non-current assets
Property, plant and equipment
64.74% 36.62M 177.53% 39.37M 73.42% 22.23M -1.99% 14.19M
Long-term receivables
10.76% 57.83M 103.59% 81.99M 148.57% 52.21M 242.97% 40.27M
Intangible assets
833.39% 62.45M 398.77% 6.51M 689.96% 6.69M 45.48% 1.31M
Special items of non-current assets
773.73% 76.54M 678.34% 62.59M 11.72% 8.76M 13763.79% 8.04M
Total non-current assets
159.7% 233.44M 198.5% 190.45M 111.46% 89.89M 134.83% 63.8M
Total assets
23.91% 2.89B 27.52% 3.76B -32.21% 2.33B 80.79% 2.95B
Liabilities
Current liabilities
Other payables and accrued expenses
32.72% 445.06M 57.65% 708.53M 326.41% 335.35M 380.3% 449.44M
Bank loans and overdrafts
-- 5.05M -- 2.66M -- -- -- --
Financial lease liabilities-current liabilities
509.19% 9.75M 99.17% 8.65M -72.28% 1.6M -- 4.34M
Deferred income-current liabilities
37.07% 7.21M 72.49% 7.21M -- 5.26M -- 4.18M
Special items of current liabilities
-- -- -- -- -- 1.89M -- --
Total current liabilities
35.74% 467.07M 58.76% 727.05M 307.61% 344.1M -58.71% 457.96M
Net current assets
15.34% 2.19B 17.14% 2.85B -42.7% 1.9B 389.96% 2.43B
Total assets less current liabilities
21.86% 2.42B 21.78% 3.04B -40.75% 1.99B 376.71% 2.49B
Non-current liabilities
Long-term bank loan
184.18% 67.62M -- 54.34M -- 23.79M -- --
Financial lease liabilities-non-current liabilities
14785.29% 15.18M -- 18.21M -92.76% 102K -- --
Deferred income-non-current liabilities
-22.07% 8.47M -21.63% 8.7M 21.36% 10.87M 46.72% 11.1M
Total non-current liabilities
162.51% 91.27M 631.98% 81.24M 235.34% 34.77M 46.72% 11.1M
Total liabilities
47.37% 558.34M 72.32% 808.29M 299.7% 378.86M -58% 469.06M
Total assets less total liabilities
19.36% 2.33B 19.06% 2.95B -41.61% 1.95B 381.55% 2.48B
Total equity and non-current liabilities
21.86% 2.42B 21.78% 3.04B -40.75% 1.99B 376.71% 2.49B
Equity
Share capital
15.43% 793K 14.56% 787K 1.78% 687K 458.54% 687K
Reserve
19.05% 2.33B 19.06% 2.95B -41.46% 1.96B 381.54% 2.48B
Legal reserve
19.05% 2.33B 19.06% 2.95B -41.46% 1.96B 381.54% 2.48B
Special items of shareholders' rights and interests
99.69% -16K 36.67% -19K -19619.23% -5.13M -- -30K
Shareholders' Equity
19.36% 2.33B 19.06% 2.95B -41.61% 1.95B 381.55% 2.48B
Total equity
19.36% 2.33B 19.06% 2.95B -41.61% 1.95B 381.55% 2.48B
Total equity and total liabilities
23.91% 2.89B 27.52% 3.76B -32.21% 2.33B 80.79% 2.95B
Currency Unit
CNYCNYCNYCNY
Accounting Standards
IASIASIASIAS
Audit Opinions
--Unqualified Opinion--Unqualified Opinion
Auditor
--Deloitte Guan Huang Chen Fang Accountants--Deloitte Guan Huang Chen Fang Accountants

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%